Position in ERAS
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$3,925,850
+$3,222,726 QoQ
Shares Held
242,636
+28.4% QoQ
Ownership
0.078%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 17.318122619891525.ToString("F0")%
Shared 0.ToString("F0")%
None 82.68187738010847.ToString("F0")%
Common Shares in ERAS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RHUMBLINE ADVISERS holds $1,237,828,718 across 284 Biotechnology names. ERAS ranks #53 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
423,140 | $188,948,935 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,781 | $121,907,911 | |
| 3 | INCY |
Incyte Corp
|
693,665 | $65,287,749 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
195,277 | $64,611,300 | |
| 5 | INSM |
INSMED Inc
|
272,615 | $44,578,004 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
164,542 | $31,106,665 | |
| 7 | EXEL |
Exelixis, Inc.
|
723,931 | $31,049,400 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
1,113,266 | $30,837,468 |
All Filings in ERAS
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,925,850 | 242,636 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $703,124 | 189,012 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $439,379 | 201,550 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $255,925 | 201,516 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $286,936 | 209,443 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $561,958 | 223,888 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $580,092 | 212,488 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $364,891 | 154,615 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $250,308 | 121,509 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $250,500 | 117,606 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $236,894 | 120,251 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $324,780 | 117,674 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $333,586 | 110,826 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $420,561 | 97,578 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $761,264 | 97,598 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $511,136 | 91,766 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $553,453 | 64,355 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $307,580 | 19,742 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $374,363 | 17,642 | Shares | Sole | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||